AG: Associate Professor, University of Nebrask Medical Center; DG: Assistant Professor, University of Texas Southwestern Medical Center

• 1. Lung Cancer Epidemiology, Etiology, and Risk Factors ; 2. Biology of Lung Cancer ; 3. Pathology of Lung Cancer ; 4. Clinical Manifestations of Lung Cancer ; 5. Diagnostic evaluation and Staging of Lung Cancer ; 6. Early Stage Non-Small Cell Lung Cancer ; 7. Locally Advanced NSCLC ; 8. Metastatic Non-small Cell Lung Cancer ; 9. Special Populations ; 10. Small Cell Lung Cancer ; 11. Pulmonary Neuroendocrine Tumors ; 12. Mesothelioma ; 13. Supportive Care in Lung Cancer

This is a very good summary of pertinent topics for clinicians who treat patients with lung cancer. In addition to a basic review of epidemiology and biological mechanisms, it succinctly reviews relevant new information about targetable mutations.

AG: Associate Professor, University of Nebrask Medical Center; DG: Assistant Professor, University of Texas Southwestern Medical Center

• 1. Lung Cancer Epidemiology, Etiology, and Risk Factors ; 2. Biology of Lung Cancer ; 3. Pathology of Lung Cancer ; 4. Clinical Manifestations of Lung Cancer ; 5. Diagnostic evaluation and Staging of Lung Cancer ; 6. Early Stage Non-Small Cell Lung Cancer ; 7. Locally Advanced NSCLC ; 8. Metastatic Non-small Cell Lung Cancer ; 9. Special Populations ; 10. Small Cell Lung Cancer ; 11. Pulmonary Neuroendocrine Tumors ; 12. Mesothelioma ; 13. Supportive Care in Lung Cancer

This is a very good summary of pertinent topics for clinicians who treat patients with lung cancer. In addition to a basic review of epidemiology and biological mechanisms, it succinctly reviews relevant new information about targetable mutations.

AG: Associate Professor, University of Nebrask Medical Center; DG: Assistant Professor, University of Texas Southwestern Medical Center

• 1. Lung Cancer Epidemiology, Etiology, and Risk Factors ; 2. Biology of Lung Cancer ; 3. Pathology of Lung Cancer ; 4. Clinical Manifestations of Lung Cancer ; 5. Diagnostic evaluation and Staging of Lung Cancer ; 6. Early Stage Non-Small Cell Lung Cancer ; 7. Locally Advanced NSCLC ; 8. Metastatic Non-small Cell Lung Cancer ; 9. Special Populations ; 10. Small Cell Lung Cancer ; 11. Pulmonary Neuroendocrine Tumors ; 12. Mesothelioma ; 13. Supportive Care in Lung Cancer

This is a very good summary of pertinent topics for clinicians who treat patients with lung cancer. In addition to a basic review of epidemiology and biological mechanisms, it succinctly reviews relevant new information about targetable mutations.